시장조사 보고서 : 세계의 나노 생명 공학 시장예측 2021년-2026년

■ 영문 제목 : Global Nanobiotechnology Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02235 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 122 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 나노 생명 공학의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (나노 메디신, 나노 의료 기기, 나노 진단, 기타)와 용도별 시장규모 (항암제, CNS 제품, 항감염증, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 나노 생명 공학 시장 점유율
- 지역별 나노 생명 공학 시장규모
- 주요지역의 종류별 시장규모 (나노 메디신, 나노 의료 기기, 나노 진단, 기타)
- 주요지역의 용도별 시장규모 (항암제, CNS 제품, 항감염증, 기타)
- 미주의 나노 생명 공학 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 나노 생명 공학 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 나노 생명 공학 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 나노 생명 공학 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 나노 생명 공학 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith & Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Nanobiotechnology will have significant change from previous year. By the most conservative estimates of global Nanobiotechnology market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Nanobiotechnology market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Nanobiotechnology market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Anticancer
CNS Product
Anti-infective
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanobiotechnology Market Size 2016-2026
2.1.2 Nanobiotechnology Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Nanobiotechnology Segment by Type
2.2.1 Nanomedicine
2.2.2 Nanomedicine
2.2.3 Nano Diagnosis
2.2.4 Other
2.3 Nanobiotechnology Market Size by Type
2.3.1 Global Nanobiotechnology Market Size CAGR by Type
2.3.2 Global Nanobiotechnology Market Size Market Share by Type (2016-2021)
2.4 Nanobiotechnology Segment by Application
2.4.1 Anticancer
2.4.2 CNS Product
2.4.3 Anti-infective
2.4.4 Other
2.5 Nanobiotechnology Market Size by Application
2.5.1 Global Nanobiotechnology Market Size CAGR by Application
2.5.2 Global Nanobiotechnology Market Size Market Share by Application (2016-2021)

3 Nanobiotechnology Market Size by Players
3.1 Nanobiotechnology Market Size Market Share by Players
3.1.1 Global Nanobiotechnology Revenue by Players (2019-2021E)
3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2019-2021E)
3.2 Global Nanobiotechnology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Nanobiotechnology by Regions
4.1 Nanobiotechnology Market Size by Regions (2016-2021)
4.2 Americas Nanobiotechnology Market Size Growth (2016-2021)
4.3 APAC Nanobiotechnology Market Size Growth (2016-2021)
4.4 Europe Nanobiotechnology Market Size Growth (2016-2021)
4.5 Middle East & Africa Nanobiotechnology Market Size Growth (2016-2021)

5 Americas
5.1 Americas Nanobiotechnology Market Size by Country (2016-2021)
5.2 Americas Nanobiotechnology Market Size by Type (2016-2021)
5.3 Americas Nanobiotechnology Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Nanobiotechnology Market Size by Region (2016-2021)
6.2 APAC Nanobiotechnology Market Size by Type (2016-2021)
6.3 APAC Nanobiotechnology Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Nanobiotechnology by Country (2016-2021)
7.2 Europe Nanobiotechnology Market Size by Type (2016-2021)
7.3 Europe Nanobiotechnology Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Nanobiotechnology by Region (2016-2021)
8.2 Middle East & Africa Nanobiotechnology Market Size by Type (2016-2021)
8.3 Middle East & Africa Nanobiotechnology Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Nanobiotechnology Market Forecast
10.1 Global Nanobiotechnology Forecast by Regions (2021-2026)
10.1.1 Global Nanobiotechnology Forecast by Regions (2021-2026)
10.1.2 Americas Nanobiotechnology Forecast
10.1.3 APAC Nanobiotechnology Forecast
10.1.4 Europe Nanobiotechnology Forecast
10.1.5 Middle East & Africa Nanobiotechnology Forecast
10.2 Americas Nanobiotechnology Forecast by Countries (2021-2026)
10.2.1 United States Nanobiotechnology Market Forecast
10.2.2 Canada Nanobiotechnology Market Forecast
10.2.3 Mexico Nanobiotechnology Market Forecast
10.2.4 Brazil Nanobiotechnology Market Forecast
10.3 APAC Nanobiotechnology Forecast by Region (2021-2026)
10.3.1 China Nanobiotechnology Market Forecast
10.3.2 Japan Nanobiotechnology Market Forecast
10.3.3 Korea Nanobiotechnology Market Forecast
10.3.4 Southeast Asia Nanobiotechnology Market Forecast
10.3.5 India Nanobiotechnology Market Forecast
10.3.6 Australia Nanobiotechnology Market Forecast
10.4 Europe Nanobiotechnology Forecast by Country (2021-2026)
10.4.1 Germany Nanobiotechnology Market Forecast
10.4.2 France Nanobiotechnology Market Forecast
10.4.3 UK Nanobiotechnology Market Forecast
10.4.4 Italy Nanobiotechnology Market Forecast
10.4.5 Russia Nanobiotechnology Market Forecast
10.5 Middle East & Africa Nanobiotechnology Forecast by Region (2021-2026)
10.5.1 Egypt Nanobiotechnology Market Forecast
10.5.2 South Africa Nanobiotechnology Market Forecast
10.5.3 Israel Nanobiotechnology Market Forecast
10.5.4 Turkey Nanobiotechnology Market Forecast
10.5.5 GCC Countries Nanobiotechnology Market Forecast
10.6 Global Nanobiotechnology Forecast by Type (2021-2026)
10.7 Global Nanobiotechnology Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Nanobiotechnology Product Offered
11.1.3 Amgen Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Information
11.2.2 Teva Pharmaceuticals Nanobiotechnology Product Offered
11.2.3 Teva Pharmaceuticals Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Teva Pharmaceuticals Main Business Overview
11.2.5 Teva Pharmaceuticals Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Nanobiotechnology Product Offered
11.3.3 Abbott Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 UCB
11.4.1 UCB Company Information
11.4.2 UCB Nanobiotechnology Product Offered
11.4.3 UCB Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 UCB Main Business Overview
11.4.5 UCB Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Nanobiotechnology Product Offered
11.5.3 Roche Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Celgene
11.6.1 Celgene Company Information
11.6.2 Celgene Nanobiotechnology Product Offered
11.6.3 Celgene Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Celgene Main Business Overview
11.6.5 Celgene Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Nanobiotechnology Product Offered
11.7.3 Sanofi Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Merck & Co
11.8.1 Merck & Co Company Information
11.8.2 Merck & Co Nanobiotechnology Product Offered
11.8.3 Merck & Co Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Merck & Co Main Business Overview
11.8.5 Merck & Co Latest Developments
11.9 Biogen
11.9.1 Biogen Company Information
11.9.2 Biogen Nanobiotechnology Product Offered
11.9.3 Biogen Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Biogen Main Business Overview
11.9.5 Biogen Latest Developments
11.10 Stryker
11.10.1 Stryker Company Information
11.10.2 Stryker Nanobiotechnology Product Offered
11.10.3 Stryker Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Stryker Main Business Overview
11.10.5 Stryker Latest Developments
11. Gilead Sciences
11.11.1 Gilead Sciences Company Information
11.11.2 Gilead Sciences Nanobiotechnology Product Offered
11.11.3 Gilead Sciences Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Gilead Sciences Main Business Overview
11.11.5 Gilead Sciences Latest Developments
11.12 Pfizer
11.12.1 Pfizer Company Information
11.12.2 Pfizer Nanobiotechnology Product Offered
11.12.3 Pfizer Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Pfizer Main Business Overview
11.12.5 Pfizer Latest Developments
11.13 3M Company
11.13.1 3M Company Company Information
11.13.2 3M Company Nanobiotechnology Product Offered
11.13.3 3M Company Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 3M Company Main Business Overview
11.13.5 3M Company Latest Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Information
11.14.2 Johnson & Johnson Nanobiotechnology Product Offered
11.14.3 Johnson & Johnson Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Johnson & Johnson Main Business Overview
11.14.5 Johnson & Johnson Latest Developments
11.15 Smith & Nephew
11.15.1 Smith & Nephew Company Information
11.15.2 Smith & Nephew Nanobiotechnology Product Offered
11.15.3 Smith & Nephew Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Smith & Nephew Main Business Overview
11.15.5 Smith & Nephew Latest Developments
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Information
11.16.2 Leadiant Biosciences Nanobiotechnology Product Offered
11.16.3 Leadiant Biosciences Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Leadiant Biosciences Main Business Overview
11.16.5 Leadiant Biosciences Latest Developments
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Information
11.17.2 Kyowa Hakko Kirin Nanobiotechnology Product Offered
11.17.3 Kyowa Hakko Kirin Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Kyowa Hakko Kirin Main Business Overview
11.17.5 Kyowa Hakko Kirin Latest Developments
11.18 Shire
11.18.1 Shire Company Information
11.18.2 Shire Nanobiotechnology Product Offered
11.18.3 Shire Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Shire Main Business Overview
11.18.5 Shire Latest Developments
11.19 Ipsen
11.19.1 Ipsen Company Information
11.19.2 Ipsen Nanobiotechnology Product Offered
11.19.3 Ipsen Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Ipsen Main Business Overview
11.19.5 Ipsen Latest Developments
11.20 Endo International
11.20.1 Endo International Company Information
11.20.2 Endo International Nanobiotechnology Product Offered
11.20.3 Endo International Nanobiotechnology Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Endo International Main Business Overview
11.20.5 Endo International Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Nanobiotechnology Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Nanomedicine
Table 3. Major Players of Nano Medical Devices
Table 4. Major Players of Nano Diagnosis
Table 5. Major Players of Other
Table 6. Nanobiotechnology Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Nanobiotechnology Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Nanobiotechnology Market Size Market Share by Type (2016-2021)
Table 9. Nanobiotechnology Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Nanobiotechnology Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Nanobiotechnology Market Size Market Share by Application (2016-2021)
Table 12. Global Nanobiotechnology Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Nanobiotechnology Revenue Market Share by Players (2019-2021E)
Table 14. Nanobiotechnology Key Players Head office and Products Offered
Table 15. Nanobiotechnology Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nanobiotechnology Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Nanobiotechnology Market Size Market Share by Regions 2016-2021
Table 20. Americas Nanobiotechnology Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Nanobiotechnology Market Size Market Share by Country (2016-2021)
Table 22. Americas Nanobiotechnology Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Nanobiotechnology Market Size Market Share by Type (2016-2021)
Table 24. Americas Nanobiotechnology Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Nanobiotechnology Market Size Market Share by Application (2016-2021)
Table 26. APAC Nanobiotechnology Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Nanobiotechnology Market Size Market Share by Region (2016-2021)
Table 28. APAC Nanobiotechnology Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Nanobiotechnology Market Size Market Share by Type (2016-2021)
Table 30. APAC Nanobiotechnology Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Nanobiotechnology Market Size Market Share by Application (2016-2021)
Table 32. Europe Nanobiotechnology Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Nanobiotechnology Market Size Market Share by Country (2016-2021)
Table 34. Europe Nanobiotechnology Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Nanobiotechnology Market Size Market Share by Type (2016-2021)
Table 36. Europe Nanobiotechnology Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Nanobiotechnology Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Nanobiotechnology Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Nanobiotechnology Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Nanobiotechnology Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Nanobiotechnology Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Nanobiotechnology Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Nanobiotechnology Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Nanobiotechnology
Table 45. Key Application and Potential Industries of Nanobiotechnology
Table 46. Key Challenges of Nanobiotechnology
Table 47. Key Trends of Nanobiotechnology
Table 48. Global Nanobiotechnology Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Nanobiotechnology Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Nanobiotechnology Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Nanobiotechnology Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Nanobiotechnology Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Nanobiotechnology Market Size Market Share Forecast by Application (2021-2026)
Table 54. Amgen Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 55. Amgen Nanobiotechnology Product Offered
Table 56. Amgen Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. Amgen Main Business
Table 58. Amgen Latest Developments
Table 59. Teva Pharmaceuticals Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 60. Teva Pharmaceuticals Nanobiotechnology Product Offered
Table 61. Teva Pharmaceuticals Main Business
Table 62. Teva Pharmaceuticals Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Teva Pharmaceuticals Latest Developments
Table 64. Abbott Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 65. Abbott Nanobiotechnology Product Offered
Table 66. Abbott Main Business
Table 67. Abbott Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Abbott Latest Developments
Table 69. UCB Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 70. UCB Nanobiotechnology Product Offered
Table 71. UCB Main Business
Table 72. UCB Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. UCB Latest Developments
Table 74. Roche Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 75. Roche Nanobiotechnology Product Offered
Table 76. Roche Main Business
Table 77. Roche Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Roche Latest Developments
Table 79. Celgene Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 80. Celgene Nanobiotechnology Product Offered
Table 81. Celgene Main Business
Table 82. Celgene Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Celgene Latest Developments
Table 84. Sanofi Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 85. Sanofi Nanobiotechnology Product Offered
Table 86. Sanofi Main Business
Table 87. Sanofi Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Sanofi Latest Developments
Table 89. Merck & Co Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 90. Merck & Co Nanobiotechnology Product Offered
Table 91. Merck & Co Main Business
Table 92. Merck & Co Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. Merck & Co Latest Developments
Table 94. Biogen Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 95. Biogen Nanobiotechnology Product Offered
Table 96. Biogen Main Business
Table 97. Biogen Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. Biogen Latest Developments
Table 99. Stryker Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 100. Stryker Nanobiotechnology Product Offered
Table 101. Stryker Main Business
Table 102. Stryker Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. Stryker Latest Developments
Table 104. Gilead Sciences Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 105. Gilead Sciences Nanobiotechnology Product Offered
Table 106. Gilead Sciences Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Gilead Sciences Main Business
Table 108. Gilead Sciences Latest Developments
Table 109. Pfizer Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 110. Pfizer Nanobiotechnology Product Offered
Table 111. Pfizer Main Business
Table 112. Pfizer Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. Pfizer Latest Developments
Table 114. 3M Company Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 115. 3M Company Nanobiotechnology Product Offered
Table 116. 3M Company Main Business
Table 117. 3M Company Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 118. 3M Company Latest Developments
Table 119. Johnson & Johnson Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 120. Johnson & Johnson Nanobiotechnology Product Offered
Table 121. Johnson & Johnson Main Business
Table 122. Johnson & Johnson Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 123. Johnson & Johnson Latest Developments
Table 124. Smith & Nephew Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 125. Smith & Nephew Nanobiotechnology Product Offered
Table 126. Smith & Nephew Main Business
Table 127. Smith & Nephew Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 128. Smith & Nephew Latest Developments
Table 129. Leadiant Biosciences Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 130. Leadiant Biosciences Nanobiotechnology Product Offered
Table 131. Leadiant Biosciences Main Business
Table 132. Leadiant Biosciences Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 133. Leadiant Biosciences Latest Developments
Table 134. Kyowa Hakko Kirin Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 135. Kyowa Hakko Kirin Nanobiotechnology Product Offered
Table 136. Kyowa Hakko Kirin Main Business
Table 137. Kyowa Hakko Kirin Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 138. Kyowa Hakko Kirin Latest Developments
Table 139. Shire Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 140. Shire Nanobiotechnology Product Offered
Table 141. Shire Main Business
Table 142. Shire Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 143. Shire Latest Developments
Table 144. Ipsen Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 145. Ipsen Nanobiotechnology Product Offered
Table 146. Ipsen Main Business
Table 147. Ipsen Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 148. Ipsen Latest Developments
Table 149. Endo International Details, Company Type, Nanobiotechnology Area Served and Its Competitors
Table 150. Endo International Nanobiotechnology Product Offered
Table 151. Endo International Main Business
Table 152. Endo International Nanobiotechnology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 153. Endo International Latest Developments
List of Figures
Figure 1. Nanobiotechnology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nanobiotechnology Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Nanobiotechnology Market Size Market Share by Type in 2020
Figure 7. Nanobiotechnology in Anticancer
Figure 8. Global Nanobiotechnology Market: Anticancer (2016-2021) & ($ Millions)
Figure 9. Nanobiotechnology in CNS Product
Figure 10. Global Nanobiotechnology Market: CNS Product (2016-2021) & ($ Millions)
Figure 11. Nanobiotechnology in Anti-infective
Figure 12. Global Nanobiotechnology Market: Anti-infective (2016-2021) & ($ Millions)
Figure 13. Nanobiotechnology in Other
Figure 14. Global Nanobiotechnology Market: Other (2016-2021) & ($ Millions)
Figure 15. Global Nanobiotechnology Market Size Market Share by Application in 2020
Figure 16. Global Nanobiotechnology Revenue Market Share by Player in 2020
Figure 17. Global Nanobiotechnology Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Nanobiotechnology Market Size 2016-2021 ($ Millions)
Figure 19. APAC Nanobiotechnology Market Size 2016-2021 ($ Millions)
Figure 20. Europe Nanobiotechnology Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Nanobiotechnology Market Size 2016-2021 ($ Millions)
Figure 22. Americas Nanobiotechnology Market Size Market Share by Country in 2020
Figure 23. Americas Nanobiotechnology Market Size Market Share by Type in 2020
Figure 24. Americas Nanobiotechnology Market Size Market Share by Application in 2020
Figure 25. United States Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Nanobiotechnology Market Size Market Share by Regions in 2020
Figure 29. APAC Nanobiotechnology Market Size Market Share by Type in 2020
Figure 30. APAC Nanobiotechnology Market Size Market Share by Application in 2020
Figure 31. China Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Nanobiotechnology Market Size Market Share by Country in 2020
Figure 38. Europe Nanobiotechnology Market Size Market Share by Type in 2020
Figure 39. Europe Nanobiotechnology Market Size Market Share by Application in 2020
Figure 40. Germany Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Nanobiotechnology Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Nanobiotechnology Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Nanobiotechnology Market Size Market Share by Application in 2020
Figure 48. Egypt Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Nanobiotechnology Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 54. APAC Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 55. Europe Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 57. United States Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 58. Canada Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 61. China Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 62. Japan Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 63. Korea Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 65. India Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 66. Australia Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 67. Germany Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 68. France Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 69. UK Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 70. Italy Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 71. Russia Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 72. Spain Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 75. Israel Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Nanobiotechnology Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Nanobiotechnology Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 나노 생명 공학 시장예측 2021년-2026년] (코드 : LPI-2201K02235) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 나노 생명 공학 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 사이즈 배제 크로마토그래피 컬럼 시장예측 2021년-2026년
LPI-2201K02582 / LP Information / 2021년 12월 / 본 조사보고서는 사이즈 배제 크로마토그래피 컬럼의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Size Exclusion Chromatography Column will have significant change from previous year. By the most conservative estimates of global Size Exclusion Chromatography Column market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 누설치술 시장예측 2021년-2026년
LPI-2201K02255 / LP Information / 2021년 12월 / 본 조사보고서는 누설치술의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Ostomy will have significant change from previous year. By the most conservative estimates of global Ostomy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3157.8 million in 2020. Over the next...

세계의 사이즈 배제 크로마토그래피 (SEC) HPLC 컬럼 시장예측 2021년-2026년
LPI-2201K02581 / LP Information / 2021년 12월 / 본 조사보고서는 사이즈 배제 크로마토그래피 (SEC) HPLC 컬럼의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽,...According to this latest study, the 2021 growth of Size Exclusion Chromatography (SEC) HPLC Column will have significant change from previous year. By the most conservative estimates of global Size Exclusion Chromatography (SEC) HPLC Column market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in...

세계의 Rho 관련 단백질 키나제 2 시장예측 2021년-2026년
LPI-2201K02164 / LP Information / 2021년 12월 / 본 조사보고서는 Rho 관련 단백질 키나제 2의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Rho Associated Protein Kinase 2 will have significant change from previous year. By the most conservative estimates of global Rho Associated Protein Kinase 2 market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 일로프로스트 약물 시장예측 2021년-2026년
LPI-2201K00058 / LP Information / 2021년 12월 / 본 조사보고서는 일로프로스트 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Iloprost Drugs will have significant change from previous year. By the most conservative estimates of global Iloprost Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 90 million in 2020. Over...

세계의 세보플루란 (세보플루란 소스) 시장예측 2021년-2026년
LPI-2201K02176 / LP Information / 2021년 12월 / 본 조사보고서는 세보플루란 (세보플루란 소스)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Sevoflurane (Sevoflurane Source) will have significant change from previous year. By the most conservative estimates of global Sevoflurane (Sevoflurane Source) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 126.7 million in...